Sofinnova News
Video: Sofinnova Partners 2024 annual general meeting
Related Strategy
CapitalRelated Strategy
CrossoverRelated Strategy
MD StartRelated Strategy
Digital MedicineRelated Strategy
Industrial BiotechRelated Strategy
TelethonRelated Strategy
BiovelocitaOur Annual General Meeting is a pivotal event that underscores the importance of collaboration and innovation in navigating our changing world, particularly in the current climate.
During this year's two-day event, our LPs, investment teams, and the CEOs of our portfolio companies shared stories of passion, perseverance, and the relentless pursuit of innovation to improve the health of people and the planet. These highlights remind us of the fundamentals we uphold in this period of constant change and uncertainty.
We extend our deepest gratitude to our LPs for their unwavering trust and support throughout the years. Their belief in our mission enables us to continue investing in groundbreaking science and innovation, which are essential in addressing our ever-changing world.
Check-out the video to get a glimpse of our 2024 Annual General Meeting:
Video of Sofinnova Partners 2024 Annual General Meeting
Related News
BrightHeart Announces Voluson™ Solution Store Collaboration to Deliver Expert-Level AI Support Across the Full Prenatal Ultrasound Exam
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield
NodThera Appoints Geoff McDonough, M.D., as Chief Executive Officer
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZITM, the First and Only Combination Eye Drop Approved to Treat Presbyopia
Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™